Forbes -
9 Nov 2015 20:33
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 0.7% on the day. Components of that ETF showing particular strength include shares of Celldex Therapeutics (CLDX), up about 11.1% and shares of Biocryst Pharmaceuticals (BCRX), up about 9.7% on the day.
Share this Article
Comment on this Article
Please to comment